BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, June 19, 2026
Home » Authors » Amanda Pedersen

Articles by Amanda Pedersen

Financings roundup: SI-Bone raises $11M to beef up clinical data, sales force

Aug. 19, 2010
By Amanda Pedersen
SI-Bone (San Jose, California), a company that says it is pioneering the use of a minimally invasive surgical device to treat the sacroiliac (SI) joint, has closed on an $11 million financing round for the expansion of clinical and commercial operations. New investor Skyline Ventures of Palo Alto, California led the round. (Medical Device Daily)
Read More

Deals roundup: Medtronic buying Ostetotech for about $123 million in cash

Aug. 18, 2010
By Amanda Pedersen
Medtech giant Medtronic (Minneapolis) is set to boost its market share in the demineralized bone matrix (DBM) space by acquiring Osteotech (Eatontown, New Jersey) for $6.50 a share in cash, or about $123 million. The company plans to make the new acquisition part of its Medtronic Biologics (Memphis, Tennessee) business. (Medical Device Daily)
Read More

First patient implanted in study for Gore Acuseal graft

Aug. 16, 2010
By Amanda Pedersen
W. L. Gore & Associates (Flagstaff, Arizona) reported that the first patient in an investigational device exemption study evaluating its self sealing Gore Acuseal Vascular Graft in patients on hemodialysis, has been surgically implanted with the device.(Medical Device Daily)
Read More

Zimmer reports implanting its first NCB plating system

Aug. 13, 2010
By Amanda Pedersen
Zimmer (Warsaw, Indiana) reported the first implantation of its NCB (Non-Contact Bridging) Periprosthetic Plating System. According to the company, the new orthopedic trauma product could "revolutionize" periprosthetic fracture care. (Medical Device Daily)
Read More

Deals roundup: OptiMedica to focus solely on laser cataract market

Aug. 12, 2010
By Amanda Pedersen
The cataract surgery space has been heating up this summer – almost as quickly as the 2010 heat wave scorching most of the U.S. in recent weeks – and now one company has decided to focus on cataract treatment exclusively in hopes of becoming the leader. (Medical Device Daily)
Read More

MIT device may allow glucose testing minus the finger pricks

Aug. 10, 2010
By Amanda Pedersen
Researchers at Massachusetts Institute of Technology's (MIT; Cambridge, Massachusetts) Spectroscopy Laboratory are working on a noninvasive way for diabetes patients to measure blood glucose levels using light, instead of having to prick their fingers several times a day to draw blood for testing. (Medical Device Daily)
Read More

Medicare fund expected to emain solvent until 2029

Aug. 9, 2010
By Amanda Pedersen
The financial solvency of Medicare should last until 2029 – 12 years longer than previous projections – thanks to cost-cutting measures and increased revenues included in the Affordable Care Act of 2010 (ACA), according to an annual report released Thursday by the Hospital Insurance (HI) and Supplemental Medical Insurance (SMI) boards of trustees. (Medical Device Daily)
Read More

Analyst shares observations, projections of SMBG market

Aug. 6, 2010
By Amanda Pedersen
Just as diabetics have to keep a close watch on their blood glucose levels, the companies that make self-monitoring blood glucose (SMBG) devices would be wise to keep a close eye on trends that impact the SMBG market. (Medical Device Daily)
Read More

FDA clears ICU Medical's Neutron IV line connector

Aug. 5, 2010
By Amanda Pedersen
After losing a patient due to an accidental IV line disconnect, George Lopez, MD, a practicing internist, imagined that there must be a better way of securing IV lines. He conceived a product, later known as the Click Lock, which provided a locking mechanism for IV systems and also was comprised of a protected needle to prevent healthcare workers from accidental needle sticks. (Medical Device Daily)
Read More

GenSpera acquires rights to cancer imaging technology

Aug. 4, 2010
By Amanda Pedersen
Sometimes having too many choices for something is not a good thing. Other times – as is the case for GenSpera (San Antonio) right now – having a lot of options is a very good thing. (Medical Device Daily)
Read More
Previous 1 2 … 137 138 139 140 141 142 143 144 145 … 222 223 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing